Search Keyword

Sunway Healthcare Group (SHG) is pleased to announce the signing of a memorandum of Understanding (MoU) with ClinChoice Clinical Research Sdn. Bhd, marking another important milestone in strengthening Malaysia’s clinical research landscape and expanding access to innovative healthcare solutions.

As medical science continues to advance at a rapid pace, collaboration between healthcare institutions and research organisations has become increasingly important in bringing new treatments to patients faster and more efficiently. Through this partnership, SHG hopes to leverage ClinChoice Clinical Research’s expertise in regional clinical operations to attract more clinical research opportunities towards the Group’s network of hospitals, creating greater access to innovative therapies for patients across Malaysia. For many patients, clinical trials represent more than just research. They represent possibility; they provide access to emerging therapies and contribute to the development of future treatments that may improve and extend lives.

Through this collaboration, ClinChoice Clinical Research and SHG also wish to explore joint strategies and educational initiatives to raise disease awareness, especially in areas of unmet needs, and clinical trial awareness. The parties also pledged to work together to cultivate clinical research talent development, enhancing the local clinical research community.

While the signing of the MoU marks the beginning of a partnership, its true impact will be measured in the opportunities it creates for researchers, healthcare professionals and, most importantly, the patients who may benefit from tomorrow’s treatments today.